Researchers have identified chemical compounds derived from a fungus that could help treat an aggressive cancer, the Journal of Antibiotics reports. 

The compounds, named paramyfurans A and B and paramylactone, were extracted from a fungal strain called Paramyrothecium sp. BF-1049. They were tested against three mesothelioma cell lines in a laboratory setting, with all three compounds showing they killed or inhibited the cancer cells. 

Mesothelioma is an aggressive cancer which is resistant to many standard treatments, so experts are actively seeking effective options. Researchers continue to screen fungal strains and other natural organisms because their chemistry can be complex and novel in ways that synthetic approaches cannot always replicate.  

“I think it’s great to harbour biological organic compounds from fungus to treat mesothelioma cell lines,” said Dr Jeffrey Velotta, thoracic surgeon at Kaiser Permanente Oakland Medical Center and mesothelioma expert. 

“This looks promising. However, before we get too excited, we’ll have to see how this compound does in animal models to see if it works in vivo, and not just in vitro.” 

“The more biological organic compounds that we can find that have “anti-cancer” activity, that is a great thing!” 

Although the findings have not been validated in clinical trials, the study could expand the list of potential drug candidates which researchers use to study further.